Hengrui Pharma H1 Revenue Dips 1.9%, Net Profit RMB 4.465B Slightly Up, Plans Up to RMB 2B Share Buyback | Earnings Watch
Hengrui Pharma reported operating revenue of RMB 15.456 billion for H1, down 1.94% year-on-year; net profit attributable to listed shareholders reached RMB 4.465 billion, up a marginal 0.34%…
Hengrui Pharma reported operating revenue of RMB 15.456 billion for H1, down 1.94% year-on-year; net profit attributable to listed shareholders reached RMB 4.465 billion, up a marginal 0.34% YoY, remaining broadly stable. Total profit stood at RMB 4.952 billion, down 1.95% YoY, with the slight net profit growth primarily supported by tax and non-operating factors.
Original: https://wallstreetcn.com/articles/3779810
insigtX content is informational and educational, not investment advice.